|
|
|
| Thyroid sarcomatoid carcinoma: a case report #br# |
| HUI Cancan SUN Yan WU Qingbin WANG Yanli WANG Fen |
| Department of Carder’s Endocrinology, the First Affiliated Hospital of Anhui Medical University, Anhui Province, Hefei 230022, China |
|
|
|
Abstract Thyroid sarcomatoid carcinoma is classified as anaplastic thyroid carcinoma, with high malignancy and poor prognosis, they are rare in thyroid cancer, and few studies have been reported in recent years. The author reports a 65-year-old man with bilateral hard thyroid glands, Ⅲ dtgree swelling, color doppler ultrasound negative, freezing during surgical exploration negative, and finally relying on postoperative pathological diagnosis of left thyroid sarcomatoid carcinoma with lymph node metastasis. Through this case, it can be seen that color doppler ultrasound can be negative for thyroid sarcomatoid carcinoma, and the final diagnosis depends on pathological features and immunohistochemistry. Clinicians need to strengthen their understanding of the disease in patients with suspected anaplastic thyroid cancer to avoid delayed diagnosis or misdiagnosis.
|
|
|
|
|
|
[1] Xu Z，Wang L，Tu L，et al. Epidemiology of and prognostic factors for patients with sarcomatoid carcinoma： a large population-based study [J]. Am J Cancer Res，2020，10（11）：3801-3814.
[2] Neff RL，Farrar WB，Kloos RT，et al. Anaplastic thyroid cancer [J]. Endocrinol Metab Clin North Am，2008，37（2）：525-538.
[3] Lebastchi AH，Callender GG. Thyroid cancer [J]. Curr Probl Cancer，2014，38（2）：48-74.
[4] Molinaro E，Romei C，Biagini A，et al. Anaplastic thyroid carcinoma：from clinicopathology to genetics and advanced therapies [J]. Nat Rev Endocrinol，2017，13（11）：644-660.
[5] Al-Qurayshi Z，Sullivan CB，Khadra H，et al. Presentation and outcomes of patients with undifferentiated thyroid carcinoma： a national perspective [J]. Gland Surg，2021，10（6）：1971-1979.
[6] Wang X，Maclennan GT，Zhang S，et al. Sarcomatoid carcinoma of the upper urinary tract：clinical outcome and molecular characterization [J]. Hum Pathol，2009，40（2）：211-217.
[7] Chang YL，Wu CT，Shih JY，et al. EGFR and p53 status of pulmonary pleomorphic carcinoma： implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy [J]. Ann Surg Oncol，2011，18（10）：2952-2960.
[8] Pelosi G，Melotti F，Cavazza A，et al. A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples [J]. Anticancer Res，2012，32（4）：1463-1473.
[9] 牛海艳，王敏健，郑少江，等.“癌肉瘤”样恶性叶状肿瘤诊断陷阱分析[J].诊断病理学杂志，2016，23（8）：605-608.
[10] 学峰，乌新林.癌相关成纤维细胞与EMT关系的研究进展[J].内蒙古医科大学学报，2018，40（4）：417-422.
[11] Dongre A，Rashidian M，Reinhardt F，et al. Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas [J]. Cancer Res，2017，77（15）：3982-3989.
[12] Nieto MA，Huang RY，Jackson RA，et al. EMT：2016 [J]. Cell，2016，166（1）：21-45.
[13] 陶慧峰，吴庆国，张晓林，等.细胞角蛋白及波形蛋白在原发性肺肉瘤样癌中的诊断价值及其与临床预后的关系[J].实用临床医药杂志，2020，24（8）：36-40.
[14] Hundahl SA，Fleming ID，Fremgen AM，et al. A National Cancer Data Base report on 53，856 cases of thyroid carcinoma treated in the U.S.，1985-1995 [see commetns][J]. Cancer，1998，83（12）：2638-2648.
[15] 侯德法，孟刚，郝大海.肉瘤样癌形态学及免疫组化观察[J].安徽医科大学学报，2008，43（6）：627-630.
[16] Yang J，Sarita-Reyes C，Kindelberger D，et al. A rare malignant thyroid carcinosarcoma with aggressive behavior and DICER1 gene mutation：a case report with literature review [J]. Thyroid Research，2018，11（1）：11.
[17] Huang NS，Shi X，Lei BW，et al. An Update of the Appropriate Treatment Strategies in Anaplastic Thyroid Cancer： A Population-Based Study of 735 Patients [J]. Int J Endocrinol，2019，2019：1-7.
[18] 范开席，王哲海.特殊表现的甲状腺癌肉瘤（附1例报告）[J].肿瘤研究与临床，2002，14（1）：55-56.
[19] 吴尧崧，陈大良.甲状腺癌肉瘤2例报告[J].中国实用外科杂志，2001，21（10）：637.
[20] 曹效忠，李瑾，郭宝良.波形蛋白作为肿瘤治疗新靶点的研究进展[J].中国普通外科杂志，2013，22（5）：643-648.
[21] 陈国芳，刘超.2012年美国甲状腺学会甲状腺未分化癌诊治指南解读[J].中华内分泌代谢杂志，2014，30（4）：284-287.
[22] Agrawal M，Uppin SG，Challa S，et al. Carcinosarcoma thyroid：An unusual morphology with a review of the literature [J]. South Asian J Cancer，2013，2（4）：226.
[23] 刘佳，崔珍.甲状腺癌肉瘤术后放疗1例[J].重庆医科大学学报，2020，45（11）：1658-1660.
[24] Keutgen XM，Sadowski SM，Kebebew E. Management of anaplastic thyroid cancer [J]. Gland Surg，2015，4（1）：44-51.
[25] 赵科，王义增，何向辉.甲状腺未分化癌相关基因与靶向治疗研究进展[J].中国中西医结合外科杂志，2017， 23（4）：457-458.
[26] Iyer PC，Dadu R，Ferrarotto R，et al. Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma [J]. Thyroid，2018，28（1）：79-87. |
|
|
|
